Yamamoto T - Search Results

1

Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump.

Kuroda A, Kaneto H, Yasuda T, Matsuhisa M, Miyashita K, Fujiki N, Fujisawa K, Yamamoto T, Takahara M, Sakamoto F, Matsuoka TA, Shimomura I. Kuroda A, et al. Among authors: yamamoto t. Diabetes Care. 2011 May;34(5):1089-90. doi: 10.2337/dc10-2149. Epub 2011 Mar 23. Diabetes Care. 2011. PMID: 21430086 Free PMC article.

2

Glycemic response during exercise after administration of insulin lispro compared with that after administration of regular human insulin.

Yamakita T, Ishii T, Yamagami K, Yamamoto T, Miyamoto M, Hosoi M, Yoshioka K, Sato T, Onishi S, Tanaka S, Fujii S. Yamakita T, et al. Among authors: yamamoto t. Diabetes Res Clin Pract. 2002 Jul;57(1):17-22. doi: 10.1016/s0168-8227(02)00014-1. Diabetes Res Clin Pract. 2002. PMID: 12007726

3

Ptf1a and RBP-J cooperate in activating Pdx1 gene expression through binding to Area III.

Miyatsuka T, Matsuoka TA, Shiraiwa T, Yamamoto T, Kojima I, Kaneto H. Miyatsuka T, et al. Among authors: yamamoto t. Biochem Biophys Res Commun. 2007 Nov 3;362(4):905-9. doi: 10.1016/j.bbrc.2007.08.076. Epub 2007 Aug 24. Biochem Biophys Res Commun. 2007. PMID: 17803961

4

Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes.

Matsuoka TA, Kaneto H, Miyatsuka T, Yamamoto T, Yamamoto K, Kato K, Shimomura I, Stein R, Matsuhisa M. Matsuoka TA, et al. Among authors: yamamoto k, yamamoto t. Diabetes. 2010 Jul;59(7):1709-20. doi: 10.2337/db08-0693. Epub 2010 Apr 27. Diabetes. 2010. PMID: 20424231 Free PMC article.

5

Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells.

Miyazaki S, Taniguchi H, Moritoh Y, Tashiro F, Yamamoto T, Yamato E, Ikegami H, Ozato K, Miyazaki J. Miyazaki S, et al. Among authors: yamamoto t. Diabetes. 2010 Nov;59(11):2854-61. doi: 10.2337/db09-1897. Epub 2010 Aug 26. Diabetes. 2010. PMID: 20798333 Free PMC article.

6

Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice.

Kawashima S, Matsuoka TA, Kaneto H, Tochino Y, Kato K, Yamamoto K, Yamamoto T, Matsuhisa M, Shimomura I. Kawashima S, et al. Among authors: yamamoto k, yamamoto t. Biochem Biophys Res Commun. 2011 Jan 7;404(1):534-40. doi: 10.1016/j.bbrc.2010.12.021. Epub 2010 Dec 7. Biochem Biophys Res Commun. 2011. PMID: 21144823

7

Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes.

Yasuda T, Kaneto H, Kuroda A, Yamamoto T, Takahara M, Naka T, Miyashita K, Fujisawa K, Sakamoto F, Katakami N, Matsuoka TA, Shimomura I. Yasuda T, et al. Among authors: yamamoto t. Diabetes Res Clin Pract. 2011 Dec;94(3):e75-7. doi: 10.1016/j.diabres.2011.08.019. Epub 2011 Sep 16. Diabetes Res Clin Pract. 2011. PMID: 21925759

8

Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

Katakami N, Mita T, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Watada H, Shimomura I; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis Trial. Katakami N, et al. Among authors: yamamoto t. J Atheroscler Thromb. 2013;20(12):893-902. doi: 10.5551/jat.18333. Epub 2013 Aug 20. J Atheroscler Thromb. 2013. PMID: 23965491 Free article. Clinical Trial.

9

Effects of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: the PROFIT-J study.

Yoshii H, Onuma T, Yamazaki T, Watada H, Matsuhisa M, Matsumoto M, Kitagawa K, Kitakaze M, Yamasaki Y, Kawamori R; PROFIT-J Study Group. Yoshii H, et al. J Atheroscler Thromb. 2014;21(6):563-73. Epub 2014 Jan 29. J Atheroscler Thromb. 2014. PMID: 24477028 Free article. Clinical Trial.

10

Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).

Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H. Mita T, et al. Among authors: yamamoto t. Diabetol Metab Syndr. 2014 Mar 10;6(1):35. doi: 10.1186/1758-5996-6-35. Diabetol Metab Syndr. 2014. PMID: 24607023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,318 results

Search Page

Filters